General Information of the Compound
| Compound ID |
CP0372939
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5,5,8,8-tetramethyl-N-(4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)-5,6,7,8-tetrahydronaphthalene-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H25N3O3
|
||||||||||||||||||
| Molecular Weight |
391.471
|
||||||||||||||||||
| Canonical SMILES |
CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)-c1nc(=O)o[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H25N3O3/c1-22(2)11-12-23(3,4)18-13-15(7-10-17(18)22)20(27)24-16-8-5-14(6-9-16)19-25-21(28)29-26-19/h5-10,13H,11-12H2,1-4H3,(H,24,27)(H,25,26,28)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CYYUVCTYGGLIIB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01475, Retinoic acid receptor alpha
Protein ID: PT01452, Retinoic acid receptor beta
Protein ID: PT01806, Retinoic acid receptor gamma